BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 32869376)

  • 1. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
    Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
    J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
    Iroegbu JD; Ifenatuoha CW; Ijomone OM
    Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
    Singal CMS; Jaiswal P; Seth P
    ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection.
    Tavassoly O; Safavi F; Tavassoly I
    ACS Chem Neurosci; 2020 Nov; 11(22):3704-3706. PubMed ID: 33147014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
    Baig AM; Sanders EC
    ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19 and the digestive system.
    Wong SH; Lui RN; Sung JJ
    J Gastroenterol Hepatol; 2020 May; 35(5):744-748. PubMed ID: 32215956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
    Bostancıklıoğlu M
    Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.
    Mahmoud IS; Jarrar YB; Alshaer W; Ismail S
    Biochimie; 2020 Aug; 175():93-98. PubMed ID: 32479856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
    Yin XX; Zheng XR; Peng W; Wu ML; Mao XY
    ACS Chem Neurosci; 2020 Jun; 11(12):1704-1705. PubMed ID: 32485101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus Disease 2019: Coronaviruses and Kidney Injury.
    Lv W; Wu M; Ren Y; Zeng N; Deng P; Zeng H; Zhang Q; Wu Y
    J Urol; 2020 Nov; 204(5):918-925. PubMed ID: 32693711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathogenesis of SARS-CoV-2 infection.
    Khan S; Gomes J
    Elife; 2020 Jul; 9():. PubMed ID: 32729463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.